{"id":68103,"date":"2022-12-19T10:00:20","date_gmt":"2022-12-19T09:00:20","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?p=68103"},"modified":"2023-10-19T11:15:37","modified_gmt":"2023-10-19T09:15:37","slug":"veeva-commercial-summit-europe-the-race-to-high-value-engagement","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/eu\/blog\/veeva-commercial-summit-europe-the-race-to-high-value-engagement\/","title":{"rendered":"Veeva Commercial Summit Europe: The Race to High-Value Engagement"},"content":{"rendered":"

Having spent the last few years embracing digital transformation in their organizations, commercial leaders are now focused on cutting through the noise to reach the right HCPs. Contrary to widespread assumption, HCP access in Europe has bounced back<\/a> to 52% from pandemic-era lows. However, not all field teams are benefiting equally: 65% of accessible HCPs choose to meet three or fewer pharma companies.<\/p>\n

The right combination of real-time customer data, analytics, and content will help life sciences companies stand out. This year\u2019s Veeva Commercial Summit, Europe, explored how organizations can improve connections between sales, medical, and marketing to achieve commercial excellence. Here are the top five Summit highlights.<\/p>\n

1. Europe\u2019s largest gathering of life sciences leaders<\/strong><\/p>\n

More than 1,100 pharma professionals joined Veeva\u2019s first in-person Commercial Summit in three years. This year\u2019s Summit featured 100+ sessions with exclusive content across four Zones: CRM Suite, Vault PromoMats and Vault Medical, Link, and OpenData. Regional roundtables also took place with industry peers on the future of customer engagement and how to drive successful hybrid engagement models.<\/p>\n

2. The race is on to high-value engagement<\/strong><\/p>\n

Keynote speaker Malcolm Crooks, COO of COUR Pharmaceuticals, is a life science veteran with 30 years of experience in launching products at Pfizer, Merck Serono, Shire, and Takeda. Crooks joined us on stage to discuss how to achieve commercial excellence in a challenging environment. Rising costs are constraining national healthcare budgets and Veeva Pulse Field Trends Report<\/a> shows that HCPs are becoming more selective about which biopharma companies they meet. Crooks shared how COUR uses digital campaigns to accelerate site recruitment and analytics <\/a>to prioritize markets for its first-in-class therapies, which use nanoparticles to treat the root causes of immune diseases, including peanut allergies and celiac disease.<\/p>\n

\"\"<\/a><\/p>\n

Chris Moore, president of Veeva Europe, and Malcolm Crooks, COO of COUR Pharmaceuticals, on stage at Veeva Commercial Summit in November 2022.<\/em><\/p>\n

3. Better connections needed between sales, medical, and marketing<\/strong><\/p>\n

More than 100 customer experts shared best practices for achieving commercial excellence and improving collaboration to better serve customers. Pharma innovators discussed how software, data, and consulting are helping them raise the bar on HCP engagement. Customer speakers included:<\/p>\n